H. Lundbeck A S

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$5.3Mgeneral payments (2019-2025)
$1.3Mresearch payments (2019-2025)
691clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.0M
2020 $260K
2021 $582K
2022 $834K
2023 $944K
2024 $805K
2025 $861K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Psychiatry $2.2M
Neurology (Psychiatry & Neurology) $1.9M
Internal Medicine $176K
Endocrinology, Diabetes & Metabolism $120K
Neurological Surgery $93K
Pediatrics $87K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Gregory Mattingley Saint Charles, MO Psychiatry $411,366.31
Peter Mcallister Fairfield, CT Neurology (Psychiatry & Neurology) $297,858.17
Christoph Correll Glen Oaks, NY Psychiatry $281,947.28
Leslie Citrome Pomona, NY Psychiatry $247,065.72
Peter Goadsby Los Agneles, CA Neurology (Psychiatry & Neurology) $187,896.37
John Kane Glen Oaks, NY Psychiatry $180,868.50
Andrew Blumenfeld Carlsbad, CA Neurology (Psychiatry & Neurology) $143,257.77
Amaal Starling Scottsdale, AZ Neurology (Psychiatry & Neurology) $132,735.89
Deborah Tepper Lebanon, NH Internal Medicine $125,322.25
Gustavo Alva Orange, CA Psychiatry $125,133.32

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.